Complete Radiopharmaceutical Therapy Solutions

Learn More

Biomarker Discovery with Spatial Resolution

Explore More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

Register for Our Upcoming Webinar

 

Join us on September 28 at 11AM ET to hear from Dr. Pareen Mehta, MD speak about the development and evolution of response assessment for neuro-oncology (RANO) criteria and how subspecialty reads can address challenges in evaluating response for patients with brain neoplasms. Grab your seat:

REGISTER NOW

Join us at EANM Congress 2023

 

Join us at EANM Congress 2023 as distinguished scientist Phillip Kuo MD, PhD delivers an oral presentation “Association of Baseline Quantitative [68Ga]Ga-PSMA-11 PET Imaging Parameters with Clinical Outcomes in Patients with mCRPC Receiving [177Lu]Lu-PSMA-617: a VISION sub-study.”

Let’s Connect

Supporting >75% of RPT Programs

 

Development of radiopharmaceutical therapies & theranostics is a challenging process that requires close collaboration with experts. Learn what industry leaders are saying about radiopharmaceutical therapy development by exploring Invicro’s latest webinars, case studies, expert interviews and more.

Access Resources

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now